FDC announces successful completion of USFDA audit of API unit at Roha, Raigad

FDC Ltd has announced that the manufacturing unit located at Roha, Dist.- Raigad, Maharashtra that manufactures Active Pharmaceutical Ingredient (APIs) products has been inspected by US FDA from 20th March 2023 to 24th March 2023.

The said audit has been successfully completed by the US FDA with "No observations" (Zero 483's).

The Active Pharmaceutical Ingredients (API's) product manufactured at the above facility continues to be marketed in USA.

Shares of FDC Limited was last trading in BSE at Rs. 254.70 as compared to the previous close of Rs. 256.40. The total number of shares traded during the day was 4863 in over 410 trades.

The stock hit an intraday high of Rs. 258.65 and intraday low of 253.30. The net turnover during the day was Rs. 1244587.00.

Source : Equity Bulls

Keywords

FDC INE258B01022 Pharmaceuticals USFDA Inspection API Zero483